Cleerly At Aha Scientific Sessions 2023 Pennsylvania Pa Join us at aha 2023. as a leader in ai applied cardiac technology, cleerly is proud to participate in the american heart association’s annual exchange of ideas, research, and innovation to accelerate novel solutions in cardiology and reduce the high number of preventable heart attacks. Cleerly is attending #aha23! connect with us at booth 1738 or in the health innovation pavilion at pod 2726. cleerly at aha scientific sessions 2023 | pennsylvania, pa reflections from aha.
Cleerly At Aha Scientific Sessions 2023 Pennsylvania Pa Denver – november 11, 2023 cleerly, the company working to create a new standard of care for the diagnosis of heart disease, today announced the transform trial at the american heart association’s (aha) 2023 scientific sessions. transform is a randomized trial – sponsored by cleerly – that aims to enroll 7,500 patients who have pre. Cleerly partnered with the cross industry organizations in the above image to announce the transform trial in november 2023 at aha scientific sessions in philadelphia. as we look ahead to 2024, i know i can speak for myself and our entire team at cleerly in saying we are invigorated by our achievements over the past year and we remain. Cleerly is attending #aha23!connect with us at booth 1738 or in the health innovation pavilion at pod 2726. or, request your one on one meeting on our website!. Aha 2023 is happening soon! have a snack and meet our founder dr. james k. min—one of insider’s top 100 people in ai—at sunday’s meet and greet, 2 3 p.m. you….
Cleerly At Aha Scientific Sessions 2023 Pennsylvania Pa Cleerly is attending #aha23!connect with us at booth 1738 or in the health innovation pavilion at pod 2726. or, request your one on one meeting on our website!. Aha 2023 is happening soon! have a snack and meet our founder dr. james k. min—one of insider’s top 100 people in ai—at sunday’s meet and greet, 2 3 p.m. you…. Welcome these first time exhibitors to scientific sessions. accurant biotech, booth 1442. adult congenital heart association, booth 3121. agepha pharma fz llc, booth 1545. alnylam pharmaceuticals, booth 1025. american academy of sleep medicine, booth 949. american heart technologies, booth 2630. anumana, booth 1337. Denver (business wire) cleerly, the company working to create a new standard of care for the diagnosis of heart disease, today announced the transform trial at the american heart association’s (aha) 2023 scientific sessions. transform is a randomized trial – sponsored by cleerly – that aims to enroll 7,500 patients who have pre diabetes.
Comments are closed.